In an interview with InsideHook, SōRSE’s Director of Research and Analytics and in-house Flavorist, Donna Wamsley, explains how and why things taste the way they taste, trends in the flavor industry, and what’s next in the world of cannabis food and beverage.
Over the past year, there has been a significant rise in sales of packaged beverages over dispensed since consumers are spending far more time at home. Our COO, Tyler Peterson, shares his insights on how store operators can best take advantage of these dynamics for more sales and profit.
“We’re just trying to offer the opportunity to make products with a top of the line water-soluble format and to be able to wholesale our emulsion to other clients in your state.” – Zach Hershberger, SōRSE’s Operations Manager.
Learn more about SōRSE’s mobile unit – how it’s a new way for SōRSE to work with our partners at a time when CBD and cannabis co-packers are unevenly distributed and regulated across the country.
SEATTLE–SōRSE Technology, the leading water-soluble emulsion technology designed for infusing functional ingredients into consumer goods, announces the addition of 7.5% CBD liquid emulsion for personal care products to their product suite. SōRSE is designed for product developers to make oil-based functional ingredients water-soluble and more efficacious, while also providing the consumer with a consistent, safe experience.
SōRSE, which currently powers over 60 infused products on the market, developed the 7.5% CBD emulsion for the personal care category to eliminate the current market’s sticky and unstable formulations. Personal care products offer a delivery method consumers are comfortable with and purchase frequently; consumers also expect an enjoyable and consistent experience just as they do with beverages and food items. SōRSE’s 7.5% water-soluble CBD emulsion seamlessly integrates, complements other ingredients, and can be modified for multiple SKUs.
“While we are a functional ingredient supplier, our foundation is in water-soluble emulsion technology and product development,” commented CEO Howard Lee. “It’s through our technology that we’re changing how the personal care industry works with tricky functional ingredients like CBD that consumers demand. We’ve made working with our technology and ingredients simple so that we can focus on helping our partners deliver more enjoyable, more effective products.”
SōRSE Technology is hosting a webinar on Thursday, February 25th on the benefits of water-soluble emulsion technology for personal care products to educate product developers on their new 7.5% CBD emulsion solution. Those interested in attending can register here or contact SōRSE directly at firstname.lastname@example.org for more information.
About SōRSE Technology
SōRSE Technology is the leading water-soluble emulsion technology designed for infusing functional ingredients into beverages, food items, personal care products, and medical applications. SōRSE is designed for product developers to make oil-based functional ingredients water-soluble and more efficacious, while also providing the consumer with a consistent, safe, and enjoyable experience. With over 200 years’ experience in food & beverage and an R&D team of 30+ employees, SōRSE is a partner that can take a producer from concept to commercialization quickly and efficiently.
In a recent interview with The Fly, our CEO, Howard Lee, shares why SōRSE has “more resiliency in our system than any other (emulsion) provider today” along with challenges and opportunities we face.
Participating in Dry January? WSPA-TV News Channel 7 based in South Carolina, recently featured a segment on Dry January Beverage Ideas and highlights SōRSE and describes some of our partners’, Aprch™ Beverage Co. , Kleer Sparkling Water and Mad Tasty as hydrating and restorative alternatives.
An article in The Tasting Panel Magazine highlighted SōRSE and its partners Aprch™ Beverage Co. , Kleer Sparkling Water and MAD TASTY, commenting, “SōRSE’s success in developing emulsions and flavor profiles that make it convenient for manufacturers to incorporate broad-spectrum #CBD is paving the way for more functional products across a variety of categories.”
2020 – what a year it has been! At the beginning of the year, the SōRSE team was busy working with our clients who were in the process of developing and launching products and preparing for live events. Then came March, and with it, Covid. Our work world changed, with many employees working remotely. Because SōRSE was deemed an essential business, emulsion production continued, as did the support of our clients. Instead of attending conventions and trade shows, we pivoted to hosting and attending virtual events and offering educational webinars to connect and engage with our partners and community.
2020 has been challenging for many reasons, but at SōRSE, there is much to celebrate – including over 1 billion unique views of the articles in which we’ve been featured. Here are some of the highlights from 2020.
In January, Mary Wagner and Allen Hsieh were appointed to the SōRSE Board of Directors. Mary Wagner is a recognized executive leader with a reputable career in the food industry, having created innovative products and developed measures to ensure food quality and safety. Allen Hsieh has over 25 years of experience in business and finance and has managed companies that have generated between $100 million and $500 million in revenue annually.
In February, Forbes published an interview with Ryan Tedder in which he explains why he decided to start a CBD beverage company, how he discovered SōRSE, and how SōRSE provided the best possible solution for creating his successful beverage line, Mad Tasty.
At SōRSE, one of our goals is to educate consumers on the benefits of products that utilize water-soluble emulsion technology. In March, we were able to share our knowledge on “How to Find a CBD Product That Works” with Bon Appétit magazine. In the article, we discuss important topics such as dosing, bioavailability, the differences between different types of CBD products, COAs, and how to figure out if a product is utilizing water-soluble technology.
In April, Benzinga broke the news that the first beverages to reach the Canada’s Cannabis 2.0 market had hit the shelves, and even better, they were powered by SōRSE! Our partner, The Valens Company, collaborated with A1 Cannabis Company to create Summit, a THC Citrus Water, and Basecamp, a CBD Iced Tea. We were proud to see our technology play a part in bringing these drinks to Canadian shelves.
In the beginning of August, SōRSE Technology was included in Fast Co’s Best Workplaces for Innovators list for 2020. Nearly 900 companies applied to be recognized by Fast Company, and SōRSE earned position #61 while also being the only cannabis adjacent company included on the list. Fast Company is an influential, cutting-edge magazine focused on “the future of business” with over 16 million monthly unique visitors.
In September, SōRSE announced that it was entering into a collaborative research agreement with Pascal Biosciences, advancing Pascal’s PAS-393 into clinical testing. Pascal and SōRSE would share their respective technologies to test the cannabinoid PAS-393 in human volunteers; this will enable testing of cancer patients treated with checkpoint inhibitors.
Donna Wamsley is not only our Director of Research and Analytics who works on emulsion innovation; she is also a trained flavorist, bringing a depth of knowledge on flavor and creating flavor profiles to her work. In October, Forbes published an interview with Donna in which she discusses her work at SōRSE, the process of becoming a flavorist, and flavor trends she sees emerging in 2021.
To connect with our partners and share our knowledge with them, SōRSE hosted its first annual, virtual summit in October, featuring presentations for our 50+ clients on a variety of topics on the infused food and beverage market. Topics included: Trends in Flavor, Emulsion Customization, Maturation of the Cannabis and CBD Marketplace, amongst many others.
Near the end of November, we announced the creation of SōRSE Clear, a stable, clear emulsion with a minimal sensory profile. The product made its official debut at our inaugural SōRSE Summit, which was a big win for our Science team and will be a game changer for our customers in the infused beverage space.
In November, SōRSE ventured into the Latin American marketplace by announcing a joint venture with FCM Global, based in Medellin, Colombia, which produces organic hemp and cannabis oils. By entering this partnership with FCM, SōRSE is now licensed to apply its technology to THC, CBD, and other cannabinoids in Colombia. The emulsion will be branded as “SōRSE by FCM GLOBAL.”
Three months after announcing the collaborative research agreement, SōRSE and Pascal Biosciences shared the news that they will be moving forward with clinical trials of the cannabinoid PS-393 in 2021 for cancer patients treated with checkpoint inhibitors. This will mark the first pharmaceutical use of SōRSE’s formulation technology in concert with Pascal’s intellectual property.
Emily Skrobecki Shares Her Experience Working at SōRSE During the Age of Covid with The Business Journals’ Bizwomen
At the beginning of December, Bizwomen published an essay written by our Process Engineering Manager, Emily Skrobecki, in which she explained how she prioritizes aspects of her job and communicates with her team while working remotely. Emily’s piece illustrates how SōRSE employees are committed to contributing to the company’s success and can adjust the way they work to fit any difficult situation.
If you’re interested in learning more about SōRSE and its accomplishments this year, download our Annual Report that summarizes the myriad ways we’ve innovated and expanded our product offerings, services, and production in 2020. We’ve learned a lot from the challenges we faced in 2020 and look forward to the promise and hope that 2021 brings.
Our Process Engineering Manager, Emily Skrobecki, shared her thoughts with BizWomen on how Covid has impacted the way she works with the team and how she prioritizes aspects of her job. Read the full article.
SEATTLE & VANCOUVER, British Columbia–Pascal Biosciences Inc. (TSX.V:PAS) (OTC:BIMUF) (“Pascal” or the “Company”) and SōRSE Technology Corporation (“SōRSE”) have validated and optimized a formula for oral cannabinoid delivery. Their shared efforts are advancing the cannabinoid PAS-393 towards clinical testing against cancer.
“This progress is very promising because this step is critical for testing in human volunteers,” said Pascal CEO Patrick Gray. “We will next identify a drug product manufacturer to prepare our product for testing in cancer patients treated with checkpoint inhibitors.”
It will be the first pharmaceutical use of the novel formulation technology developed by SōRSE and the first clinical trial for Pascal and SōRSE. This collaboration utilizes propriety discoveries by both companies, including Pascal’s intellectual property, which covers the use of cannabinoids in cancer patients treated with checkpoint inhibitors, and SōRSE’s proprietary formulation expertise.
“It’s great to see such rapid progress with the in vitro studies using our formulation technology,” said SōRSE CEO Howard Lee. “We are on track to enter our first clinical trial with Pascal within a year.”
Following characterization of safety and pharmacology in a Phase 1a clinical trial, Pascal and SōRSE may elect to continue clinical development as equal partners in a Phase 1b cancer trial in combination with a checkpoint inhibitor.
About Pascal Biosciences Inc.
Pascal is a biotechnology company targeting innovative therapies for serious diseases, including COVID-19. Pascal is also developing treatments for cancer with targeted therapies for acute lymphoblastic leukemia and cannabinoid-based therapeutics. Pascal’s leading portfolio also comprises a small molecule therapeutic, PAS-403, that is advancing into clinical trials for the treatment of glioblastoma, and PAS-393, an immuno-stimulatory cannabinoid to be used in combination with checkpoint inhibitor therapy. For more information, visit www.pascalbiosciences.com.
About SōRSE Technology
SōRSE Technology Corporation is a water-soluble emulsion technology designed for product developers to provide consumers with a better, more consistent cannabinoid experience with greater bioavailability, near-perfect dosing, shelf-stability, and safe ingredients. Its patent-pending technology converts oil into SōRSE, a proprietary water-soluble emulsion, for infusing CBD and other functional ingredients into beverages, food items, topicals, and medical applications. SōRSE Technology currently powers more than 45 leading products in the CBD space. For more information, visit www.sorsetechnology.com.
SōRSE Technology Press:
Jon Lindsay Phillips